{"id":"placebo-plus-metformin","safety":{"commonSideEffects":[{"rate":"10-30","effect":"Gastrointestinal disturbance (nausea, diarrhea, abdominal discomfort)"},{"rate":"3-10","effect":"Metallic taste"},{"rate":"<0.1","effect":"Lactic acidosis (rare)"},{"rate":"10-30","effect":"Vitamin B12 deficiency"}]},"_chembl":{"chemblId":"CHEMBL1431","moleculeType":"Small molecule","molecularWeight":"129.17"},"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Placebo plus metformin","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T02:38:49.273454+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T02:38:56.250437+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Placebo plus metformin","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T02:38:57.122144+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1431/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T02:38:57.629922+00:00"}},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Metformin is a biguanide that decreases gluconeogenesis in the liver and enhances peripheral glucose uptake and utilization. In this combination, metformin provides the active therapeutic effect for glycemic control in diabetes, while the placebo component serves as a control comparator in the clinical study design.","oneSentence":"Metformin reduces hepatic glucose production and improves insulin sensitivity, while the placebo control arm receives no active pharmacological intervention.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:01:19.363Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:38:59.783950+00:00","fieldsConflicting":0,"overallConfidence":0.95},"indications":{"approved":[{"name":"Type 2 diabetes mellitus"}]},"trialDetails":[{"nctId":"NCT02122185","phase":"PHASE2","title":"Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2015-02-25","conditions":"Brenner Tumor, Malignant Ascites, Malignant Pleural Effusion","enrollment":111},{"nctId":"NCT07485764","phase":"PHASE4","title":"Metformin Combined With Secukinumab for Moderate-to-Severe Plaque Psoriasis in Overweight or Obese Chinese Patients","status":"NOT_YET_RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2026-06","conditions":"Psoriasis, Plaque Psoriasis, Moderate-to-severe Plaque Psoriasis","enrollment":186},{"nctId":"NCT06231758","phase":"PHASE3","title":"Metformin Safety and Efficacy in Osteoarthritis.","status":"RECRUITING","sponsor":"Mostafa Bahaa","startDate":"2024-01-30","conditions":"Osteo Arthritis Knee","enrollment":70},{"nctId":"NCT01351753","phase":"PHASE2","title":"Drug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With Obesity","status":"TERMINATED","sponsor":"University of Iowa","startDate":"2011-03","conditions":"Obesity, Metabolic Syndrome X","enrollment":128},{"nctId":"NCT04596631","phase":"PHASE3","title":"A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2020-11-02","conditions":"Diabetes Mellitus, Type 2","enrollment":132},{"nctId":"NCT07433062","phase":"PHASE1","title":"A Study to Evaluate the Effect of AZD6793 on the Pharmacokinetics and Pharmacodynamics of Metformin in Participants With Type 2 Diabetes Mellitus","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2026-01-14","conditions":"Type 2 Diabetes Mellitus","enrollment":28},{"nctId":"NCT05279768","phase":"PHASE1, PHASE2","title":"Stem Cells and Secretomes for Infertility Therapy in Polycystic Ovary Syndrome (PCOS) Patients With Insulin Resistance.","status":"COMPLETED","sponsor":"PT. Prodia Stem Cell Indonesia","startDate":"2022-09-01","conditions":"Polycystic Ovary Syndrome","enrollment":44},{"nctId":"NCT06611501","phase":"PHASE2","title":"Glycemic Regulation as Endometriosis Adjunct Treatment","status":"RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2025-05-22","conditions":"Pelvic Pain, Endometriosis","enrollment":14},{"nctId":"NCT03514108","phase":"PHASE4","title":"DANHEART (H-HeFT and Met-HeFT)","status":"COMPLETED","sponsor":"Henrik Wiggers","startDate":"2018-03-01","conditions":"Heart Failure, Diabetes","enrollment":1100},{"nctId":"NCT07395895","phase":"PHASE3","title":"Effect of Metformin Iontophoresis on Knee Osteoarthritis in Postmenopausal Women","status":"NOT_YET_RECRUITING","sponsor":"Badr University","startDate":"2026-03-01","conditions":"Osteoarthritis in Postmenopausal Women","enrollment":68},{"nctId":"NCT07395960","phase":"PHASE1, PHASE2","title":"The Efficacy and Safety of Metformin Intervention in Elderly Overweight or Obesity With Mild Cognitive Impairment","status":"RECRUITING","sponsor":"Fudan University","startDate":"2025-09-01","conditions":"Mild Cognitive Impairment, Overweight or Obesity, Elderly","enrollment":54},{"nctId":"NCT06090227","phase":"PHASE1, PHASE2","title":"AMPK-activation by Metformin in FSGS: AMP-FSGS","status":"RECRUITING","sponsor":"Yale University","startDate":"2023-12-14","conditions":"Focal Segmental Glomerulosclerosis","enrollment":30},{"nctId":"NCT07379333","phase":"PHASE3","title":"A Study to Evaluate Efficacy and Safety of HM11260C in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin","status":"NOT_YET_RECRUITING","sponsor":"Hanmi Pharmaceutical Company Limited","startDate":"2026-02","conditions":"Type 2 Diabetes","enrollment":118},{"nctId":"NCT04341571","phase":"PHASE2","title":"Effect of Probiotics Versus Metformin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Prediabetes.","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Guadalajara","startDate":"2019-10-24","conditions":"PreDiabetes, Impaired Glucose Tolerance, Hyperglycemia","enrollment":30},{"nctId":"NCT05230758","phase":"PHASE3","title":"Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour","status":"RECRUITING","sponsor":"Donald Mabbott","startDate":"2022-07-01","conditions":"Medulloblastoma, Childhood, Cognitive Impairment","enrollment":140},{"nctId":"NCT06065540","phase":"PHASE3","title":"A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2023-09-27","conditions":"Type 2 Diabetes Mellitus","enrollment":2734},{"nctId":"NCT07007221","phase":"PHASE2","title":"Clinical Trials to Evaluate Metformin to Treat Depression in People Living With HIV","status":"NOT_YET_RECRUITING","sponsor":"University of Minnesota","startDate":"2026-07-01","conditions":"Depression, Hiv","enrollment":600},{"nctId":"NCT03862950","phase":"PHASE2","title":"A Trial of Metformin in Individuals With Fragile X Syndrome (Met)","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2019-05-24","conditions":"Fragile X Syndrome, Fragile X Mental Retardation Syndrome, Mental Retardation, X-Linked","enrollment":125},{"nctId":"NCT00971243","phase":"PHASE2","title":"Efficacy and Safety of MP-513 in Combination With Metformin in Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Tanabe Pharma Corporation","startDate":"2009-08","conditions":"Type 2 Diabetes Mellitus","enrollment":448},{"nctId":"NCT05093959","phase":"PHASE2","title":"Metformin for Older Patients With Heart Failure With Preserved Ejection Fraction","status":"ACTIVE_NOT_RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2022-01-04","conditions":"Heart Failure With Preserved Ejection Fraction","enrollment":86},{"nctId":"NCT07321223","phase":"NA","title":"Comparison of Different Doses of Vitamin D Supplementation on Glycated Haemoglobin and Blood Glucose Parameters With Type II Diabetes Mellitus Having Vitamin d Deficiency","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Lahore","startDate":"2024-08-22","conditions":"Diabetes (DM), Vitamin D Deficiency","enrollment":108},{"nctId":"NCT02924064","phase":"PHASE3","title":"Efficacy and Safety of Teneligliptin in Combination With Metformin in Chinese Patients With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Tanabe Pharma Corporation","startDate":"2016-09","conditions":"Type 2 Diabetes Mellitus","enrollment":247},{"nctId":"NCT04221750","phase":"PHASE3","title":"Diet and Exercise Plus Metformin to Treat Frailty in Obese Seniors","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2021-05-14","conditions":"Frailty, Sarcopenic Obesity, Aging","enrollment":114},{"nctId":"NCT07303127","phase":"NA","title":"Combination of Bitter Melon Extract and Snakehead Fish Powder to Reduce Glycaemia in Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Universitas Muhammadiyah Surakarta","startDate":"2021-06-01","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":80},{"nctId":"NCT07302932","phase":"NA","title":"Metformin and Molecular Aging in Prediabetes","status":"COMPLETED","sponsor":"Diabetes Foundation, India","startDate":"2023-02-01","conditions":"Metformin, Prediabetes","enrollment":112},{"nctId":"NCT06297603","phase":"PHASE3","title":"Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Eli Lilly and Company","startDate":"2024-03-15","conditions":"Type 2 Diabetes","enrollment":320},{"nctId":"NCT05838573","phase":"PHASE3","title":"Metformin Treatment on Cognitive Impairment of Schizophrenia","status":"RECRUITING","sponsor":"Central South University","startDate":"2023-05-08","conditions":"Schizophrenia","enrollment":120},{"nctId":"NCT07057479","phase":"PHASE3","title":"Phase III Trial of SGLT2 Inhibitor and Thiazolidinedione Fixed-Dose Combination vs. Monotherapy in Type 2 Diabetes Patients on Metformin","status":"WITHDRAWN","sponsor":"Eurofarma Laboratorios S.A.","startDate":"2026-09","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":""},{"nctId":"NCT06560333","phase":"PHASE3","title":"iSGLT2 Inhibitor and a iDPP -4 Inhibitor in Treatment of Type 2 Diabetes Mellitus in Patients Treated With Metformin (TRIAD)","status":"WITHDRAWN","sponsor":"Eurofarma Laboratorios S.A.","startDate":"2026-11-30","conditions":"Diabetes Mellitus, Type 2","enrollment":""},{"nctId":"NCT02915198","phase":"PHASE4","title":"Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2023-04-03","conditions":"Prediabetic State, Atherosclerosis, Metformin","enrollment":7410},{"nctId":"NCT05131828","phase":"PHASE2","title":"CCMR Two: A Phase IIa, Randomised, Double-blind, Placebo-controlled Trial of the Ability of the Combination of Metformin and Clemastine to Promote Remyelination in People With Relapsing-remitting Multiple Sclerosis Already on Disease-modifying Therapy","status":"COMPLETED","sponsor":"Cambridge University Hospitals NHS Foundation Trust","startDate":"2022-03-08","conditions":"Multiple Sclerosis","enrollment":70},{"nctId":"NCT06983223","phase":"NA","title":"Oral Sucrosomial® Vitamin B12 in the Management of B12 Deficiency Among Metformin-Treated Type 2 Diabetes Patients","status":"COMPLETED","sponsor":"Liaquat University of Medical & Health Sciences","startDate":"2025-08-15","conditions":"Vitamin B 12 Deficiency, Type 2 Diabetes Mellitus (T2DM)","enrollment":50},{"nctId":"NCT06393348","phase":"PHASE2","title":"Efficacy and Safety of HRS-7535 Tablets in T2DM Subjects Poorly Controlled With Metformin and SGLT2i.","status":"COMPLETED","sponsor":"Shandong Suncadia Medicine Co., Ltd.","startDate":"2024-05-17","conditions":"Type 2 Diabetes","enrollment":155},{"nctId":"NCT06280274","phase":"PHASE4","title":"Metformin Use in Patients Undergoing Total Joint Replacement Surgery","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2024-06-27","conditions":"Hyperglycemia","enrollment":40},{"nctId":"NCT06323161","phase":"PHASE3","title":"A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Once-daily Basal Insulin With or Without Metformin","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2024-03-26","conditions":"Type 2 Diabetes","enrollment":274},{"nctId":"NCT06353347","phase":"PHASE3","title":"Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controlled With Metformin","status":"COMPLETED","sponsor":"HighTide Biopharma Pty Ltd","startDate":"2023-11-13","conditions":"Type 2 Diabetes Mellitus","enrollment":551},{"nctId":"NCT05532813","phase":"PHASE3","title":"Evaluation of the Efficacy and Safety of Metformin in the Myotonic Dystrophy Type 1 (Steinert's Disease)","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-11-29","conditions":"Steinert's Disease, Myotonic Dystrophy 1, Metformin","enrollment":142},{"nctId":"NCT06463743","phase":"PHASE2","title":"Metformin as an add-on or Monotherapy in Treatment of Aging People With Multiple Sclerosis (MS)","status":"RECRUITING","sponsor":"State University of New York at Buffalo","startDate":"2025-09-24","conditions":"Multiple Sclerosis","enrollment":30},{"nctId":"NCT07241897","phase":"PHASE3","title":"DPP4 Inhibitor Intervention on Post-stroke Cognitive Impairment in Ischemic Stroke Patients With Type 2 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital of Soochow University","startDate":"2025-12-15","conditions":"Ischemic Stroke, Diabete Mellitus","enrollment":312},{"nctId":"NCT06571591","phase":"PHASE3","title":"Efficacy and Safety of Pioglitazone Combination Therapy in Type 2 Diabetes Patients on a Background of Empagliflozin With Metformin","status":"ACTIVE_NOT_RECRUITING","sponsor":"Celltrion","startDate":"2024-08-27","conditions":"T2DM","enrollment":582},{"nctId":"NCT06042855","phase":"PHASE3","title":"ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin)","status":"COMPLETED","sponsor":"Susanna Naggie, MD","startDate":"2023-09-05","conditions":"Covid19","enrollment":3214},{"nctId":"NCT04578652","phase":"PHASE3","title":"Fiber and Metformin Combination Therapy in Adolescents With Severe Obesity and Insulin Resistance","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2021-10-22","conditions":"Obesity, Childhood, Insulin Resistance","enrollment":90},{"nctId":"NCT07229534","phase":"PHASE4","title":"Clinical Trial to Evaluate the Efficacy and Safety of DA-5218 in Patients With Type 2 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Dong-A ST Co., Ltd.","startDate":"2025-11","conditions":"Diabete Mellitus","enrollment":238},{"nctId":"NCT04885530","phase":"PHASE3","title":"ACTIV-6: COVID-19 Study of Repurposed Medications","status":"COMPLETED","sponsor":"Susanna Naggie, MD","startDate":"2021-06-08","conditions":"Covid19","enrollment":10956},{"nctId":"NCT06446531","phase":"PHASE1","title":"Prevention of Progression of Prediabetes, Obesity and CV Risk","status":"RECRUITING","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2024-09-11","conditions":"Pre-Diabetes, Weight, Body, Cardiovascular Diseases","enrollment":64},{"nctId":"NCT03229057","phase":"PHASE3","title":"Comparing the Effects of Oral Contraceptive Pills Versus Metformin","status":"COMPLETED","sponsor":"Anuja Dokras","startDate":"2018-01-15","conditions":"PCOS","enrollment":240},{"nctId":"NCT04029480","phase":"PHASE3","title":"Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2019-10-08","conditions":"Type 2 Diabetes Mellitus","enrollment":166},{"nctId":"NCT06109311","phase":"PHASE3","title":"A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2023-11-10","conditions":"Type 2 Diabetes","enrollment":546},{"nctId":"NCT05237960","phase":"PHASE2","title":"Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Arizona","startDate":"2023-01-12","conditions":"Erythroplakia, Oral Leukoplakia","enrollment":34},{"nctId":"NCT07026968","phase":"PHASE3","title":"A Study of Prusogliptin Tablets Combined With Dapagliflozin Tablets and Metformin Hydrochloride Extended Release Tablets in Type 2 Diabetes","status":"ENROLLING_BY_INVITATION","sponsor":"CSPC Ouyi Pharmaceutical Co., Ltd.","startDate":"2025-06-20","conditions":"Type 2 Diabetes","enrollment":815},{"nctId":"NCT05260021","phase":"PHASE3","title":"A Study to Evaluate Tirzepatide (LY3298176) in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin or Basal Insulin or Both","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2022-04-13","conditions":"Type2 Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2","enrollment":99},{"nctId":"NCT04121468","phase":"PHASE1, PHASE2","title":"A Phase I Double Blind Study of Metformin Acting on Endogenous Neural Progenitor Cells in Children and Young Adults With Multiple Sclerosis","status":"RECRUITING","sponsor":"The Hospital for Sick Children","startDate":"2020-02-24","conditions":"Multiple Sclerosis (MS)","enrollment":20},{"nctId":"NCT03355469","phase":"PHASE2, PHASE3","title":"Exercise Dose and Metformin for Vascular Health in Metabolic Syndrome","status":"COMPLETED","sponsor":"Rutgers University","startDate":"2017-08-07","conditions":"Metabolic Syndrome","enrollment":91},{"nctId":"NCT03617458","phase":"PHASE2","title":"Interventions Against Insulin Resistance in Pulmonary Arterial Hypertension","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2018-08-23","conditions":"Pulmonary Artery Hypertension","enrollment":73},{"nctId":"NCT06707012","phase":"PHASE4","title":"Efficacy of Metformin as an Adjunct to Standard Antidepressant Therapy in Treating Depression Among Obese Patients","status":"RECRUITING","sponsor":"Fazaia Ruth Pfau Medical College","startDate":"2025-10-01","conditions":"Depression","enrollment":140},{"nctId":"NCT07179042","phase":"EARLY_PHASE1","title":"Intertrochanteric Femur Fracture Patients Who Receive Metformin With a Placebo","status":"ENROLLING_BY_INVITATION","sponsor":"University of Utah","startDate":"2025-09-04","conditions":"Intertrochanteric Femur Fracture, Muscle Atrophy","enrollment":60},{"nctId":"NCT07145827","phase":"NA","title":"Effect of Metformin on Endometrial Thickness in Postmenopausal Breast Cancer Patients Receiving Tamoxifen","status":"COMPLETED","sponsor":"Uruk University","startDate":"2024-01-02","conditions":"Breast Cancer, Endometrial Hyperplasia and Endometrial Cancers","enrollment":60},{"nctId":"NCT05132439","phase":"PHASE3","title":"MetfOrmin BenefIts Lower Extremities With Intermittent Claudication","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2022-03-01","conditions":"Intermittent Claudication","enrollment":200},{"nctId":"NCT03054519","phase":"PHASE3","title":"Improve PAD PERformance With METformin","status":"ACTIVE_NOT_RECRUITING","sponsor":"Northwestern University","startDate":"2017-05-23","conditions":"Peripheral Artery Disease","enrollment":203},{"nctId":"NCT07131384","phase":"NA","title":"Interaction Between Inorganic Nitrate Supplementation and Metformin in Individuals With Prediabetes","status":"NOT_YET_RECRUITING","sponsor":"University of Virginia","startDate":"2025-09-01","conditions":"Males, Females, Sedentary","enrollment":24},{"nctId":"NCT07109700","phase":"PHASE2","title":"A Study of HDM1005 in Participants With T2DM Not Controlled With Diet/Exercise or Metformin","status":"RECRUITING","sponsor":"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.","startDate":"2025-04-30","conditions":"Type 2 Diabetes","enrollment":216},{"nctId":"NCT07093476","phase":"PHASE3","title":"Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin","status":"RECRUITING","sponsor":"Celltrion","startDate":"2025-07-18","conditions":"T2DM, Diabete Type 2, DM","enrollment":171},{"nctId":"NCT05243654","phase":"PHASE2","title":"Efficacy and Tolerability of Adjunct Metformin for Multibacillary Leprosy","status":"RECRUITING","sponsor":"Oxford University Clinical Research Unit Indonesia","startDate":"2022-10-01","conditions":"Leprosy, Leprosy, Multibacillary, Neglected Tropical Diseases","enrollment":166},{"nctId":"NCT05744479","phase":"PHASE4","title":"Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual Disability","status":"RECRUITING","sponsor":"Centre for Addiction and Mental Health","startDate":"2023-02-28","conditions":"Intellectual Disability, Developmental Disability, Obesity","enrollment":100},{"nctId":"NCT06649773","phase":"PHASE3","title":"The Experiment of Noiiglutide Injection in Type 2 Diabetes Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jiangsu HengRui Medicine Co., Ltd.","startDate":"2024-10-25","conditions":"Type 2 Diabetes","enrollment":137},{"nctId":"NCT06481085","phase":"PHASE2","title":"To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.","startDate":"2024-06-27","conditions":"Type 2 Diabetes","enrollment":324},{"nctId":"NCT07076056","phase":"PHASE3","title":"Clinical Trial to Evaluate the Efficacy and Safety of DW1026C1 or DW1026C2","status":"COMPLETED","sponsor":"Daewon Pharmaceutical Co., Ltd.","startDate":"2022-10-27","conditions":"Type 2 Diabetes","enrollment":230},{"nctId":"NCT06846138","phase":"NA","title":"Enhancing the Efficacy and Tolerability of Metformin by add-on Polyherbal Formulation: a Gut Microbiome Study","status":"ENROLLING_BY_INVITATION","sponsor":"Pauls Stradins Clinical University Hospital","startDate":"2025-03-01","conditions":"Diabetes Mellitus Type 2","enrollment":66},{"nctId":"NCT02040376","phase":"PHASE3","title":"Metformin for Brain Repair in Children With Cranial-Spinal Radiation for Medulloblastoma","status":"COMPLETED","sponsor":"The Hospital for Sick Children","startDate":"2014-06-13","conditions":"Brain Tumor Treated With Cranial or Cranial-Spinal Radiation","enrollment":24},{"nctId":"NCT01825798","phase":"PHASE3","title":"Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD)","status":"COMPLETED","sponsor":"Holland Bloorview Kids Rehabilitation Hospital","startDate":"2013-04","conditions":"Overweight, Autism Spectrum Disorder","enrollment":60},{"nctId":"NCT07065591","phase":"EARLY_PHASE1","title":"Anti-Diabetic Drug, Exercise and Healthy Diet for Knee Osteoarthritis With Overweight/Obesity","status":"NOT_YET_RECRUITING","sponsor":"The University of Hong Kong","startDate":"2025-10-01","conditions":"Osteoarthritis (OA) of the Knee","enrollment":100},{"nctId":"NCT04767841","phase":"PHASE1, PHASE2","title":"The AMPK Modulator Metformin as a Novel Adjunct to Conventional Therapy in Patients With Knee Osteoarthritis","status":"WITHDRAWN","sponsor":"Sadat City University","startDate":"2021-02-16","conditions":"Osteo Arthritis Knee","enrollment":""},{"nctId":"NCT04068246","phase":"PHASE1, PHASE2","title":"The AMPK Modulator Metformin as a Novel Adjunct to Conventional Therapy in Rheumatoid Arthritis Patients","status":"COMPLETED","sponsor":"Sadat City University","startDate":"2019-08-01","conditions":"Rheumatoid Arthritis","enrollment":120},{"nctId":"NCT07055958","phase":"PHASE3","title":"Effect of Metformin as Add-on Therapy in Levodopa Treated Parkinson's Disease Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","startDate":"2024-12-29","conditions":"Parkinson Disease","enrollment":74},{"nctId":"NCT07057271","phase":"PHASE3","title":"A Study of CJC-1134-PC Injection in Patients With Type 2 Diabetes With Inadequately Controlled Blood Glucose Level After Metformin Monotherapy or Metformin in Combination With Insulin Secretagogues","status":"COMPLETED","sponsor":"Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd.","startDate":"2021-05-27","conditions":"Type 2 Diabetes Mellitus - Poor Control","enrollment":464},{"nctId":"NCT02500147","phase":"PHASE4","title":"Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)","status":"TERMINATED","sponsor":"Columbia University","startDate":"2011-09-08","conditions":"Polycystic Ovary Syndrome, Non-Alcoholic Fatty Liver Disease, Metabolic Syndrome","enrollment":3},{"nctId":"NCT04939935","phase":"PHASE3","title":"Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD)","status":"RECRUITING","sponsor":"The University of Queensland","startDate":"2022-11-29","conditions":"Autosomal Dominant Polycystic Kidney Disease","enrollment":1174},{"nctId":"NCT06924658","phase":"PHASE2","title":"Metformin in Safety and Efficacy in Gouty Patients","status":"RECRUITING","sponsor":"Mostafa Bahaa","startDate":"2025-04-20","conditions":"Gout","enrollment":70},{"nctId":"NCT04207944","phase":"PHASE2","title":"The Prevention of Progression to Pancreatic Cancer Trial (The 3P-C Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Duke University","startDate":"2020-07-10","conditions":"IPMN, IPMN, Pancreatic","enrollment":100},{"nctId":"NCT05065372","phase":"PHASE1","title":"MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes","status":"RECRUITING","sponsor":"Kalie Tommerdahl","startDate":"2022-07-01","conditions":"Type 1 Diabetes, Diabetic Kidney Disease, Cardiovascular Diseases","enrollment":60},{"nctId":"NCT01697566","phase":"PHASE3","title":"An Endometrial Cancer Chemoprevention Study of Metformin","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2013-05-30","conditions":"Gynecology","enrollment":29},{"nctId":"NCT03686657","phase":"PHASE1, PHASE2","title":"Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes Patients","status":"NOT_YET_RECRUITING","sponsor":"ARKAY Therapeutics","startDate":"2025-10-10","conditions":"Type 2 Diabetes, High Blood Pressure, Arthritis","enrollment":115},{"nctId":"NCT06999343","phase":"PHASE3","title":"Exploring the Anti-ageing Effects of Metformin in COPD","status":"NOT_YET_RECRUITING","sponsor":"Fundación Instituto de Investigación Sanitaria de Navarra","startDate":"2025-09-01","conditions":"COPD","enrollment":212},{"nctId":"NCT01135433","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Type 2 Diabetic Patients","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2010-05-15","conditions":"Type 2 Diabetes Mellitus","enrollment":168},{"nctId":"NCT01071850","phase":"PHASE2","title":"A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2010-03-03","conditions":"Diabetes Mellitus, Type 2","enrollment":412},{"nctId":"NCT01117584","phase":"PHASE2","title":"A Study to Evaluate the Effect of ASP1941 in Combination With Metformin in Adult Patients With Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2010-04-06","conditions":"Type 2 Diabetes Mellitus","enrollment":343},{"nctId":"NCT06937294","phase":"PHASE4","title":"Metformin in Post Chronic Pancreatitis Diabetes Mellitus","status":"RECRUITING","sponsor":"Changhai Hospital","startDate":"2025-04-28","conditions":"Chronic Pancreatitis","enrollment":58},{"nctId":"NCT05949008","phase":"PHASE4","title":"Effect of Metformin, a Drug Used to Treat Diabetes, vs Placebo","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2023-11-22","conditions":"NIDDM, Obesity","enrollment":150},{"nctId":"NCT04264897","phase":"PHASE3","title":"Antecedent Metabolic Health and Metformin Aging Study","status":"COMPLETED","sponsor":"Oklahoma Medical Research Foundation","startDate":"2020-07-29","conditions":"Aging, Insulin Sensitivity, Chronic Disease","enrollment":101},{"nctId":"NCT03109873","phase":"EARLY_PHASE1","title":"Metformin Hydrochloride in Affecting Cytokines and Exosomes in Patients With Head and Neck Cancer","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","startDate":"2017-01-05","conditions":"Larynx, Lip, Oral Cavity","enrollment":9},{"nctId":"NCT05900466","phase":"PHASE2","title":"Metformin for Fibromyalgia Symptoms (INFORM Trial)","status":"RECRUITING","sponsor":"University of Utah","startDate":"2023-04-01","conditions":"Fibromyalgia Syndrome","enrollment":72},{"nctId":"NCT04500756","phase":"PHASE2","title":"Limiting AAA With Metformin (LIMIT) Trial","status":"RECRUITING","sponsor":"Stanford University","startDate":"2022-02-28","conditions":"Abdominal Aortic Aneurysm","enrollment":314},{"nctId":"NCT06687265","phase":"PHASE2","title":"Effects of Metformin on Hepatic Venous Pressure Gradient in Patients With Cirrhosis and Portal Hypertension","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-03-10","conditions":"Cirrhosis, Portal Hypertension Related to Cirrhosis","enrollment":76},{"nctId":"NCT01905046","phase":"PHASE3","title":"Metformin Hydrochloride in Preventing Breast Cancer in Patients With Atypical Hyperplasia or In Situ Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2015-11-23","conditions":"Atypical Ductal Breast Hyperplasia, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier","enrollment":86},{"nctId":"NCT06829238","phase":"PHASE4","title":"Assessment of Metformin for Restoration of Immune Homeostasis in HIV+ and HIV- Individuals With a History of Injection Drug Use","status":"RECRUITING","sponsor":"University of Alabama at Birmingham","startDate":"2025-04-07","conditions":"Systemic Inflammation, Immune Dysregulation, Injection Drug Use","enrollment":100},{"nctId":"NCT06033131","phase":"PHASE3","title":"PI4 - A Trial Assessing Metformin to Prolong Gestation in Preterm Preeclampsia","status":"RECRUITING","sponsor":"Lina Bergman","startDate":"2024-01-19","conditions":"Preeclampsia","enrollment":294},{"nctId":"NCT05998837","phase":"PHASE2, PHASE3","title":"GLUcose Transport and REnalPROtection in Chronic Kidney Disease","status":"COMPLETED","sponsor":"IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy","startDate":"2021-04-13","conditions":"Chronic Kidney Disease, Diabetes Mellitus, Type 2, Hypertension","enrollment":34},{"nctId":"NCT06000462","phase":"PHASE4","title":"The Effect of Dapagliflozin on Weight Loss in Obese Adults Without Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Oman Ministry of Health","startDate":"2024-04-22","conditions":"Obesity, Dapagliflozin Adverse Reaction, Weight Loss","enrollment":150},{"nctId":"NCT04979130","phase":"PHASE4","title":"Comparing Semaglutide Versus Placebo on Intestinal Barrier Function in Type 2 Diabetes Mellitus (SIB)","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2022-01-01","conditions":"Type 2 Diabetes, Chronic Inflammation, Intestinal Permeability","enrollment":69},{"nctId":"NCT02980276","phase":"PHASE3","title":"RCT Metformin for Reduction of Gestational Diabetes Mellitus Effects","status":"COMPLETED","sponsor":"National University of Ireland, Galway, Ireland","startDate":"2017-06-06","conditions":"Gestational Diabetes","enrollment":535}],"_emaApprovals":[],"_faersSignals":[],"crossReferences":{"chemblId":"CHEMBL1431"},"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Placebo plus metformin","genericName":"Placebo plus metformin","companyName":"University Magna Graecia","companyId":"university-magna-graecia","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Metformin reduces hepatic glucose production and improves insulin sensitivity, while the placebo control arm receives no active pharmacological intervention. Used for Type 2 diabetes mellitus.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:38:59.783950+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}